People / Staff

Ignacio Aznar Lou

Search publications

Publications

  • Soler M, Aznar I, Almansa J, Peña P, Silva-Peñaherrera M, Serra C and Ramada JM.

    Cost-Effectiveness of a Multi-faceted Workplace Intervention to Reduce Musculoskeletal Pain in Nursing Staff: A Cluster-Randomized Controlled Trial (INTEVAL_Spain).

    J OCCUP REHABIL . 35(3): 602-614. Number of citations: 2

    [doi:10.1007/s10926-024-10227-6]

  • Peñarrubia-María MT, Parker LA, Puig-García M, Fuente M, Lumbreras B, Lopez-Pintor E, Domènech J, Saez M, Dima AL, Figueiras Guzmán A, Chilet Rosell E, Serrano-Blanco A and Aznar I.

    Challenge of long-term benzodiazepine use in primary care: insights from a real-world cohort study in Catalonia.

    Family Medicine and Community Health . 13(3): .

    [doi:10.1136/fmch-2024-003233]

  • Paut Kusturica M, Sanchez A, Lumbreras B, Huerta-Ramos ME, Aznar I and Rubio-Valera M.

    Assessing direct medical costs of children following a new prescription of ADHD medication.

    BMC HEALTH SERVICES RESEARCH . 25(1): 990-990.

    [doi:10.1186/s12913-025-13106-9]

  • Nieto-Casado FJ, Gómez-Gómez I, Aznar I, Barquero-Jiménez C, Cáceres I, Carretero S, Company-Córdoba R, De-Juan-Iglesias P, Domínguez-Salas S, Gil-Cosano JJ, Goossens L, Rodríguez-Domínguez C and Motrico E.

    A personalized mHealth intervention for the universal prevention of perinatal mental disorders in routine maternal care (e-Perinatal): A protocol study for a hybrid feasibility pilot trial.

    Open Research Europe . 5: 170-170.

    [doi:10.12688/openreseurope.20386.1]

  • Rubio-Valera M, Carbonell-Duacastella C, Peñarrubia-María MT, Pacheco E, Gabriela-Ricciardeli P, Aznar I and Gil MM.

    Insights on pediatric medication initiation: perceptions of caregivers and children.

    FRONTIERS IN PHARMACOLOGY . 16: 1612169-1612169. Number of citations: 1

    [doi:10.3389/fphar.2025.1612169]

  • Soler M, Ribera A, Aznar I, Sanchez A, Slof J, Vela E, Salvat-Plana M, Villa-García L, Serrano-Blanco A, Pérez de la Osa N, Ribó M and Abilleira S.

    Costs during the first year after stroke by degree of functional disability: A societal perspective.

    European Stroke Journal . 10(2): 513-523.

    [doi:10.1177/23969873241301904]

  • Andersohn F, Christensen MC, Creuwels L, Aznar I, Rubio-Valera M, Penning-van Beest F, Houben E, Hernandez P, Hakkarainen KM and Reines EH.

    Vortioxetine in the routine management of major depressive disorder: an analysis of European automated healthcare databases.

    CURRENT MEDICAL RESEARCH AND OPINION . 41(5): 867-877.

    [doi:10.1080/03007995.2025.2505692]

  • Fuente M, Cahir C, Passos VL, Bennett K, Walsh C, Hermida-González P, Peláez de Loño J, Abella MER, Baladon L, Rubio-Valera M, Serrano-Blanco A and Aznar I.

    Identifying longitudinal medication adherence patterns of antipsychotic treatments: A real-world cohort study in Catalonia, Spain

    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY . : . Number of citations: 1

    [doi:10.1111/bcp.16399]

  • Vargas I, Mogollón-Pérez AS, Eguiguren P, Torres AL, Peralta A, Rubio-Valera M, Jervelund SS, Borras JM, Dias S and Vázquez ML.

    Understanding the health system drivers of delayed cancer diagnosis in public healthcare networks of Chile, Colombia and Ecuador: A qualitative study with health professionals, managers and policymakers.

    SOCIAL SCIENCE & MEDICINE . 365: 117499-117499. Number of citations: 1

    [doi:10.1016/j.socscimed.2024.117499]

  • Peña C, Kazah N, Carrillo B, Díaz C, Callen A, Serrano-Blanco A and Aznar I.

    Comorbilidad neurológica en pacientes psiquiátricos ingresados: evidencia sobre interconsultas de neurología en un centro español.

    REVISTA DE NEUROLOGIA . 79(1): 11-20. Number of citations: 1

    [doi:10.33588/rn.7901.2024054]